X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GSK PHARMA UNICHEM LAB/
GSK PHARMA
 
P/E (TTM) x 284.8 53.9 528.2% View Chart
P/BV x 0.7 10.7 6.1% View Chart
Dividend Yield % 2.6 2.7 96.0%  

Financials

 UNICHEM LAB   GSK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
GSK PHARMA
Mar-18
UNICHEM LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3822,760 13.8%   
Low Rs2342,040 11.5%   
Sales per share (Unadj.) Rs116.3339.0 34.3%  
Earnings per share (Unadj.) Rs-18.941.4 -45.7%  
Cash flow per share (Unadj.) Rs-11.745.9 -25.6%  
Dividends per share (Unadj.) Rs5.0035.00 14.3%  
Dividend yield (eoy) %1.61.5 111.3%  
Book value per share (Unadj.) Rs381.0242.9 156.9%  
Shares outstanding (eoy) m70.3484.70 83.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.67.1 37.4%   
Avg P/E ratio x-16.357.9 -28.1%  
P/CF ratio (eoy) x-26.252.3 -50.2%  
Price / Book Value ratio x0.89.9 8.2%  
Dividend payout %-26.484.5 -31.3%   
Avg Mkt Cap Rs m21,668203,280 10.7%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,0065,234 38.3%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,18028,715 28.5%  
Other income Rs m610545 111.9%   
Total revenues Rs m8,79029,260 30.0%   
Gross profit Rs m-1,3205,059 -26.1%  
Depreciation Rs m505380 132.9%   
Interest Rs m802 4,005.0%   
Profit before tax Rs m-1,2955,222 -24.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m331,892 1.8%   
Profit after tax Rs m-1,3313,508 -37.9%  
Gross profit margin %-16.117.6 -91.6%  
Effective tax rate %-2.636.2 -7.1%   
Net profit margin %-16.312.2 -133.2%  
BALANCE SHEET DATA
Current assets Rs m23,31821,815 106.9%   
Current liabilities Rs m4,63515,999 29.0%   
Net working cap to sales %228.420.3 1,127.6%  
Current ratio x5.01.4 368.9%  
Inventory Days Days12264 191.5%  
Debtors Days Days12119 650.0%  
Net fixed assets Rs m8,16312,475 65.4%   
Share capital Rs m141847 16.6%   
"Free" reserves Rs m26,66019,726 135.2%   
Net worth Rs m26,80120,573 130.3%   
Long term debt Rs m36 55.0%   
Total assets Rs m31,89039,475 80.8%  
Interest coverage x-15.22,612.0 -0.6%   
Debt to equity ratio x00 42.2%  
Sales to assets ratio x0.30.7 35.3%   
Return on assets %-3.98.9 -44.1%  
Return on equity %-5.017.1 -29.1%  
Return on capital %-4.526.2 -17.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,356564 772.4%   
Fx outflow Rs m07,429 0.0%   
Net fx Rs m4,356-6,865 -63.5%   
CASH FLOW
From Operations Rs m-1,1234,728 -23.8%  
From Investments Rs m16,487-1,042 -1,582.4%  
From Financial Activity Rs m-8,811-3,066 287.3%  
Net Cashflow Rs m6,552620 1,057.3%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 15.1 10.2 148.0%  
FIIs % 3.0 23.8 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 15.4 205.8%  
Shareholders   20,176 102,036 19.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ORCHID PHARMA LTD  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 18, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS